Coffee and tea linked to lower head and neck cancer risk

Todays Updates

NeurologyLive® Brain Games: October 11, 2026 Louie Pasculli

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is recent therapeutic advances in MS!

This Week on NeurologyLive® — October 12, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Individualizing Advanced Therapies in Parkinson Disease: Hubert Fernandez, MD Hubert Fernandez, MD, Louie Pasculli

The director of the Center for Neurological Restoration at Cleveland Clinic discusses when to transition beyond oral medication and considerations for selecting device-aided therapies in PD.

What Comprehensive Disease Control Means for IBD, With David Rubin, MD David Rubin, MD

A gastroenterologist explains why treating bowel inflammation alone isn't enough to call inflammatory bowel disease "controlled."

Individualizing IBD Care Beyond the Bowel, With David T. Rubin, MD David Rubin, MD

David T. Rubin, MD, on the questions, screening tools, and system barriers standing between IBD care and the whole patient.

How Candida Moves From Mouth to Gut in IBD, With Iliyan D. Iliev, PhD Iliyan D. Iliev, PhD

Weill Cornell investigator Iliyan D. Iliev, PhD, explains why fluconazole, not nystatin, cleared gut Candida in IBD.

LIBERTY: Prior Anti-Drug Antibodies Did Not Blunt SC Infliximab After Drug Holiday

Todays Updates

NeurologyLive® Brain Games: October 11, 2026 Louie Pasculli

This Week on NeurologyLive® — October 12, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Individualizing Advanced Therapies in Parkinson Disease: Hubert Fernandez, MD Hubert Fernandez, MD, Louie Pasculli

The director of the Center for Neurological Restoration at Cleveland Clinic discusses when to transition beyond oral medication and considerations for selecting device-aided therapies in PD.

What Comprehensive Disease Control Means for IBD, With David Rubin, MD David Rubin, MD

A gastroenterologist explains why treating bowel inflammation alone isn't enough to call inflammatory bowel disease "controlled."

Individualizing IBD Care Beyond the Bowel, With David T. Rubin, MD David Rubin, MD

David T. Rubin, MD, on the questions, screening tools, and system barriers standing between IBD care and the whole patient.

How Candida Moves From Mouth to Gut in IBD, With Iliyan D. Iliev, PhD Iliyan D. Iliev, PhD

Weill Cornell investigator Iliyan D. Iliev, PhD, explains why fluconazole, not nystatin, cleared gut Candida in IBD.

LIBERTY: Prior Anti-Drug Antibodies Did Not Blunt SC Infliximab After Drug Holiday

Coffee and tea linked to lower head and neck cancer risk

Latest News

Rare Tumor in a Rare Location in Patient With Constipation

ASTRO: American Society for Radiation Oncology

A Surgical First for Removal of an Appendiceal Neoplasm

What's Behind the Mysterious Chest Pain in Bladder Cancer Patient?

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

Benign or Malignant? No Way to Tell Radiologically

Todays Updates

NeurologyLive® Brain Games: October 11, 2026 Louie Pasculli

This Week on NeurologyLive® — October 12, 2026 Isabella Ciccone, MPH

Individualizing Advanced Therapies in Parkinson Disease: Hubert Fernandez, MD Hubert Fernandez, MD, Louie Pasculli

What Comprehensive Disease Control Means for IBD, With David Rubin, MD David Rubin, MD

Individualizing IBD Care Beyond the Bowel, With David T. Rubin, MD David Rubin, MD

How Candida Moves From Mouth to Gut in IBD, With Iliyan D. Iliev, PhD Iliyan D. Iliev, PhD

LIBERTY: Prior Anti-Drug Antibodies Did Not Blunt SC Infliximab After Drug Holiday

Todays Updates

NeurologyLive® Brain Games: October 11, 2026 Louie Pasculli

This Week on NeurologyLive® — October 12, 2026 Isabella Ciccone, MPH

Individualizing Advanced Therapies in Parkinson Disease: Hubert Fernandez, MD Hubert Fernandez, MD, Louie Pasculli

What Comprehensive Disease Control Means for IBD, With David Rubin, MD David Rubin, MD

Individualizing IBD Care Beyond the Bowel, With David T. Rubin, MD David Rubin, MD

How Candida Moves From Mouth to Gut in IBD, With Iliyan D. Iliev, PhD Iliyan D. Iliev, PhD

LIBERTY: Prior Anti-Drug Antibodies Did Not Blunt SC Infliximab After Drug Holiday

Latest News

News All Time

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

More Evidence Ties Microplastics to Lung Cancer

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

9/11's Latest Wave of Cancers, 25 Years On

Study Warns on Venetoclax in Double-Hit Lymphoma

Cancer Diagnosis, Then a Stroke; 9/11 Cancer Deaths; 'Grand Slam' Drug and Price

No Survival Bump in Metastatic NSCLC With Addition of ADC to Immunotherapy

Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancer

Local Consolidative Therapy After Dual Immunotherapy Fizzles in Metastatic NSCLC

Cancer Drug Shortages Continue With No Immediate Path Toward Relief

Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer

Nurse Accused of Exorcism; Death After 8 Hours of Plastic Surgery; Top Cancer Months

ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

Unprecedented PFS in HER2-Mutant Lung Cancer, but With a Touch of Controversy

Novel Drug Cuts Risk for Death by 44% in Squamous Lung Cancer Trial

Recommended News For You

Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.

Photopenia on [18F]FDG PET/CT Predicts Benign Renal Lesions

C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

Dissociative identity disorder: method or fact?

Gotistobart Response Rate Bests Chemo in Pretreated NSCLC

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care

Recommended Articles For You

Embryonic Oxygen Consumption and Development: Clinical and Mechanistic Insights

Next-Generation Antibody–Drug Conjugates: Optimizing Payloads, Linkers, and Tumor Selectivity

Long-Term Care After Cancer Remission: Clinical Strategies, Evidence, and Future Directions

Navigating the Complexities of Esophageal Cancer Staging

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.